1. Alkire MT, Hudetz AG, Tononi G. Consciousnessand anesthesia. Science. 2008; 322(5903):876-80.2. Manuel C, Pardo Jr.Basics of Anesth. Elsevier; 213.3. Bernstein K, Gisselsson L, Jacobsson L, Ohrlander S.InfluenceofTwoDifferentAnaesthetic Agents on theNewborn and the Correlation between FoetalOxygenation and Induction‐Deliveryime in ElectiveCaesarean Section. AAC. 1985; 29(2):157-60.4. Ganning M, Perkins Z , Queenn T. Trenchentrapment: is ketaminesafe to use for sedation inhead injury. EMJ. 2007; 24: 794-95.907965. Menigaux C, Fletcher D , Dupont X. The benefits ofntraoperative small-dose ketamine on postoperativepain after anterior cruciate ligament repair. AnesthAnalg. 2000; 90: 129-35.
6. Guillou N, Tanguy M , Seguin P. The effect of smalldose ketamine on morphine consumption in surgicalintensive care unit patient after major abdominalsurgery. Anesth Analg. 2003; 97: 843-7.7. Lahtinen P, Kokki H, Hakala T and markku H. S(+)-ketamine as an analgesic adjunct reduces opioidconsumption after cardiac surgery. Anesth Analg.2004; 99:1295-1301.8. Ghodraty M, Pournajafian A, Rokhtabnak F, Feiz HAzhdarkosh H, Allame S. Evaluation of intranasal
dexmedetomidine in providing moderate sedation inpatients undergoing ERCP: A randomized controlledtrial. JMUMS. 2016; 26(143):11-9.9. Bajwa S, Kulshrestha A. Dexmedetomidine: Anadjuvant making large inroads into clinical practice.
Ann Med Health Sci Res. 2013; 3(4): 475-483.10. Belleville JP, Ward DS, BloorBC,MazeMEffectsofintravenousdexmedetomidine in humans. I.Sedation, ventilation, and metabolic rateAnesthesiology. 1992;77(6):1125-1133.11. Wijeysundera DN, Naik JS, Beattie WS. Alpha-2adrenergic agonists to prevent Perioperativecardiovascular complications: A meta-analysis. Am JMed. 2003; 114(9): 742-752.12. Aantaa R, Schienin M. Alpha 2-adrenergic agents inanesthesia. AAC. 1993; 37(5): 433-448.13. Coursin DB, Maccioli GA.Dexmedetomidine. CurrOpin Crit Care. 2001; 7(4): 221-226.14. Anttila M, Penttilä J, Helminen A, Vuorilehto L,
Scheinin H. Bioavailability of dexmedetomidine afterextravascular doses in healthy subjects. BJCP. 2003;56(6):691-3.
15. Young CC, Prielipp RC. Sedative analgesic, andneuromuscular blocking drugs. In: Critical CareMedicine: Perioperative Management, Murray MJ,Coursin DB, Pearl RG et al. 2thed. New York:Lippincott Williams & Wilkins; 2002. P. 147-167.16. Demiraran Y, Korkut E, Tamer A, Yorulmaz I,Kocaman B, Sezen G, Akcan Y. The comparison ofdexmedetomidine and midazolam used for sedation ofpatients during upper endoscopy: A prospective,randomized study. CJGH. 2007;21(1):25-9.17. Al-Waili N, Saloom KY. The analgesic effect ofintravenous tenoxicam in the symptomatic treatment
of biliary colic. Eur J Med Res. 1998;14:475–9.18.Nazemroaya B, Honarmand A, Bab Hadi Ashar M.Effects of adding dexmedetomidine o ketamine onheart rate and blood pressure changs in psychiatricpatientsundergoingelectroconvulsive therapy.Koomesh. 2020; 22 (2) :311-31619. Kamel GF, Ali RM, Ismail AE, Hanna BE.Comparative evaluation of hemodynamic stability andrecovery during conscious sedation bydexmedetomidine with fentanyl versus ketamine withfentanyl in dilatation and curettage. Egy J Hosp Med.2018; 73: 5992 - 599720. Tarek FT. Comparison of the efficacy ofdexmedetomidine, ketamine, and a mixture of both forpediatric MRI sedation. EGJA. 2013; 29(3): 241-46
21. Owens VF, Palmieri TL, Comroe CM, Conroy JM,Scavone JA, Greenhalgh DG. Ketamine: a safe andeffective agent for painful procedures in the pediatricburn patient. J Burn Care Res. 2006; 27:211–6.22. Walker J, Maccallum M, Fischer C, Kopcha R,Saylors R, McCall J. Sedation using dexmedetomidinein pediatric burn patients. J Burn Care Res. 2006;
27:206–10